Progressive multifocal leukoencephalopathy in a child with immunodeficiency and hyperimmunoglobulinemia M.
Redfearn
A
A
McMaster University Medical Centre, Hamilton, Ontario, Canada.
Pennie
R A
RA
Mahony
J B
JB
Dent
P B
PB
D015703:Antigens, CD / Q000032:analysis; D001739:BK Virus / Q000302:isolation & purification; D001921:Brain / Q000382:microbiology; D002555:Cerebrospinal Fluid / Q000382:microbiology; D002648:Child; D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006942:Hypergammaglobulinemia / Q000150:complications* / Q000188:drug therapy; D017098:IgA Deficiency / Q000150:complications*; D017099:IgG Deficiency / Q000150:complications*; D007075:Immunoglobulin M; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007577:JC Virus / Q000302:isolation & purification; D007968:Leukoencephalopathy, Progressive Multifocal / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D008297:Male; D016133:Polymerase Chain Reaction; D013601:T-Lymphocytes / Q000276:immunology; D014412:Tumor Virus Infections / Q000188:drug therapy / Q000209:etiology; D014556:Urine / Q000382:microbiology
D015703:Antigens, CD; D007075:Immunoglobulin M; D016756:Immunoglobulins, Intravenous; D003561:Cytarabine